Heart On chip based on induced pluripotent Stem cell Technology for personalized...
Heart On chip based on induced pluripotent Stem cell Technology for personalized Medicine
Many rare diseases cause chronic health problems or are even life-threatening. The impact on the quality of life of affected patients, of whom many are children, is significant. To date, a limited but increasing number of so-call...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
CAMEOS
Cardiac micro engineered tissue for high throughput screenin...
261K€
Cerrado
PoCCardio
Personalised Medicine by using an Advanced Point-of-Care Too...
13M€
Cerrado
open-TOP
Validation of Open organ on chip Technology for End user app...
150K€
Cerrado
3DCardiacHTS
Bringing 3D cardiac tissues to high throughput for drug disc...
1M€
Cerrado
PiLOC
Next Generation Lab On a Chip For Advanced Diagnostics
100K€
Cerrado
COMMiT
Cancer Organoids Multiplexed Screening in Microfluidic Texti...
150K€
Cerrado
Información proyecto CISTEM
Duración del proyecto: 68 meses
Fecha Inicio: 2017-10-04
Fecha Fin: 2023-06-30
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
Many rare diseases cause chronic health problems or are even life-threatening. The impact on the quality of life of affected patients, of whom many are children, is significant. To date, a limited but increasing number of so-called orphan drugs (drugs for rare diseases) are reaching patients. However, the majority of rare diseases are still without any effective treatment. The development of novel human systems for drug discovery therefore represents a major public health priority. Microfluidic technology-based Organs-on-a-chip represents a powerful tool for investigating rare disease mechanisms and testing new drug and treatment due to their ability to mimic tailored micro-environment architecture inspired by organ-level functions in vivo. However, due to the variability in rare disease mechanisms from one patient to another, organ on chip technology needs to be more precise and to convey towards personalized medicine. The human-induced pluripotent stem cells (iPSCs) have a strong potential in engineering organ-on-a-chip since they are derived in a patient-matched manner which makes them a superb source to construct human models for personalized drug screening as well as for understanding patient-specific fundamentals of diseases. To provide novel miniaturized platform for investigation of rare diseases able to address the burning issues in precision medicine today, CISTEM will bring together and synergistically several highly promising research directions which are too often investigated separately at the academic level but also at the industrial level. Based on 4 work packages, the CISTEM RISE project will be implemented by exploiting the complementary expertise of its partners and creating synergies between them through the targeted secondments of staff.